CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,772,000 | -38.3% | 663,800 | 0.0% | 0.59% | -25.1% |
| Q4 2021 | $2,874,000 | -54.2% | 663,800 | -46.2% | 0.79% | -51.9% |
| Q3 2021 | $6,279,000 | +15.0% | 1,233,642 | +43.0% | 1.65% | +30.1% |
| Q2 2021 | $5,459,000 | +46.2% | 862,417 | +78.5% | 1.27% | +22.2% |
| Q1 2021 | $3,734,000 | +108.3% | 483,041 | +76.5% | 1.04% | +54.9% |
| Q4 2020 | $1,793,000 | – | 273,703 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |